Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 14(1): 6515, 2024 03 18.
Article in English | MEDLINE | ID: mdl-38499634

ABSTRACT

Human pancreatic ductal adenocarcinoma (PDAC) is a highly malignant and lethal tumor of the exocrine pancreas. Cannabinoids extracted from the hemp plant Cannabis sativa have been suggested as a potential therapeutic agent in several human tumors. However, the anti-tumor effect of cannabinoids on human PDAC is not entirely clarified. In this study, the anti-proliferative and apoptotic effect of cannabinoid solution (THC:CBD at 1:6) at a dose of 1, 5, and 10 mg/kg body weight compared to the negative control (sesame oil) and positive control (5-fluorouracil) was investigated in human PDAC xenograft nude mice model. The findings showed that cannabinoids significantly decreased the mitotic cells and mitotic/apoptotic ratio, meanwhile dramatically increased the apoptotic cells. Parallelly, cannabinoids significantly downregulated Ki-67 and PCNA expression levels. Interestingly, cannabinoids upregulated BAX, BAX/BCL-2 ratio, and Caspase-3, meanwhile, downregulated BCL-2 expression level and could not change Caspase-8 expression level. These findings suggest that cannabinoid solution (THC:CBD at 1:6) could inhibit proliferation and induce apoptosis in human PDAC xenograft models. Cannabinoids, including THC:CBD, should be further studied for use as the potent PDCA therapeutic agent in humans.


Subject(s)
Cannabinoids , Cannabis , Carcinoma, Pancreatic Ductal , Pancreatic Neoplasms , Animals , Mice , Humans , Cannabinoids/pharmacology , Cannabinoids/therapeutic use , Mice, Nude , Heterografts , bcl-2-Associated X Protein , Carcinoma, Pancreatic Ductal/drug therapy , Pancreatic Neoplasms/drug therapy , Proto-Oncogene Proteins c-bcl-2
2.
Sci Rep ; 13(1): 15648, 2023 09 20.
Article in English | MEDLINE | ID: mdl-37730833

ABSTRACT

An HPMC-based nasal spray solution containing human IgG1 antibodies against SARS-CoV-2 (nasal antibody spray or NAS) was developed to strengthen COVID-19 management. NAS exhibited potent broadly neutralizing activities against SARS-CoV-2 with PVNT50 values ranging from 0.0035 to 3.1997 µg/ml for the following variants of concern (ranked from lowest to highest): Alpha, Beta, Gamma, ancestral, Delta, Omicron BA.1, BA.2, BA.4/5, and BA.2.75. Biocompatibility assessment showed no potential biological risks. Intranasal NAS administration in rats showed no circulatory presence of human IgG1 anti-SARS-CoV-2 antibodies within 120 h. A double-blind, randomized, placebo-controlled trial (NCT05358873) was conducted on 36 healthy volunteers who received either NAS or a normal saline nasal spray. Safety of the thrice-daily intranasal administration for 7 days was assessed using nasal sinuscopy, adverse event recording, and self-reporting questionnaires. NAS was well tolerated, with no significant adverse effects during the 14 days of the study. The SARS-CoV-2 neutralizing antibodies were detected based on the signal inhibition percent (SIP) in nasal fluids pre- and post-administration using a SARS-CoV-2 surrogate virus neutralization test. SIP values in nasal fluids collected immediately or 6 h after NAS application were significantly increased from baseline for all three variants tested, including ancestral, Delta, and Omicron BA.2. In conclusion, NAS was safe for intranasal use in humans to increase neutralizing antibodies in nasal fluids that lasted at least 6 h.


Subject(s)
COVID-19 , Nasal Sprays , Humans , Animals , Rats , Administration, Intranasal , Immunoglobulin G , Antibodies, Neutralizing , SARS-CoV-2 , Healthy Volunteers , Antibodies, Viral
3.
Front Vet Sci ; 9: 867575, 2022.
Article in English | MEDLINE | ID: mdl-35937289

ABSTRACT

Background: Pancreatic cancer is considered a rare type of cancer, but the mortality rate is high. Cannabinoids extracted from the cannabis plant have been interested as an alternative treatment in cancer patients. Only a few studies are available on the antitumor effects of cannabinoids in pancreatic cancer. Therefore, this study aims to evaluate the antitumor effects of cannabinoids in pancreatic cancer xenografted mouse model. Materials and Methods: Twenty-five nude mice were subcutaneously transplanted with a human pancreatic ductal adenocarcinoma cell line (Capan-2). All mice were randomly assigned into 5 groups including negative control (gavage with sesame oil), positive control (5 mg/kg 5-fluorouracil intraperitoneal administration), and cannabinoids groups that daily received THC:CBD, 1:6 at 1, 5, or 10 mg/kg body weight for 30 days, respectively. Xenograft tumors and internal organs were collected for histopathological examination and immunohistochemistry. Results: The average tumor volume was increased in all groups with no significant difference. The average apoptotic cells and caspase-3 positive cells were significantly increased in cannabinoid groups compared with the negative control group. The expression score of proliferating cell nuclear antigen in positive control and cannabinoids groups was decreased compared with the negative control group. Conclusions: Cannabinoids have an antitumor effect on the Capan-2-derived xenograft mouse model though induce apoptosis and inhibit proliferation of tumor cells in a dose-dependent manner.

4.
Asian Pac J Cancer Prev ; 4(1): 31-8, 2003.
Article in English | MEDLINE | ID: mdl-12718698

ABSTRACT

Seventeen samples of tap water in Bangkok and 2 neighboring provinces were collected in winter and summer, concentrated and tested for mutagenic activity using the Ames Salmonella mutagenesis assay. Preliminary results demonstrated that concentrated tap water exhibited clear mutagenicity towards S. typhimurium TA100 and YG1029, but not towards TA98 and YG1024, in the absence of S9 mix, and the addition of S9 mix markedly decreased the mutagenicity to both tester strains. Amberlite( ) XAD-2 resin, but not blue rayon, was able to adsorb mutagens from water at pH 2. Our data clearly demonstrated that all tap water samples prepared by chlorination of Chao Phraya River water were mutagenic to strain TA100 without S9 mix, inducing 3,351 + 741 and 2,216 + 770 revertants/l, in winter and summer, respectively. On the other hand, however, tap water samples prepared from ground water were not mutagenic. Furthermore, it was found that boiling for only 5 min and filtration through home purifying system containing activated charcoal and mixed resin units were very effective to abolish the mutagenicity of water. Storage of water also significantly decreased the mutagenicity, however, it took 2-3 weeks to totally abolish it. Additionally, we also found 1 out of 6 brands of commercially available bottled drinking water to be mutagenic, with about 26 % of the average mutagenicity of tap water. The results in the present study clearly demonstrated that chlorinated tap water in Bangkok and neighboring provinces contain direct-acting mutagens causing capable of causing base-pair substitution. Boiling and filtration of tap water through home purifying systems may be the most effective means to abolish the mutagenicity. Some brands of commercial bottled waters may also contain mutagens which may be derived from tap water.


Subject(s)
Environmental Exposure/analysis , Mutagens/analysis , Water Pollutants/analysis , Water Supply/analysis , Environmental Exposure/adverse effects , Mutagenicity Tests/methods , Mutagens/adverse effects , Salmonella typhimurium/drug effects , Seasons , Thailand/epidemiology , Water Pollutants/adverse effects , Water Purification/methods , Water Supply/statistics & numerical data
SELECTION OF CITATIONS
SEARCH DETAIL
...